<DOC>
	<DOCNO>NCT02863146</DOCNO>
	<brief_summary>HALACAP-1406 prospective single-centre non-interventional study assess refrigerant helmet use medical device prevent alopecia induce eribulin ( Halaven® ) condition use specify marketing authorization . Eribulin use alone treatment patient locally advance metastatic breast cancer progress least 1 chemotherapy regimen advance stage .</brief_summary>
	<brief_title>Efficacy Use Refrigerant Helmet Prevent Alopecia Patients Treated With Eribulin Breast Cancer</brief_title>
	<detailed_description>A nurse meet patient present study , patient invite participate . If patient interested , information note give non-opposition patient collect . Patients register via registration form inclusion number attribute patient . Eribulin use within framework marketing authorization , per cycle 21 day , day 1 day 8 . Modalities refrigerant helmet use set accord habit Oscar Lambret center follow rule : - Placement single-use non-woven hygiene cap scalp - T-15 minute : placement refrigerant helmet - T0 : begin eribulin infusion ( duration : 2-5 minute ) - T+15 minute : rinse line - T+30 minute : withdrawal helmet Efficacy evaluate treatment eribulin cycle .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Alopecia</mesh_term>
	<mesh_term>Alopecia Areata</mesh_term>
	<criteria>Female patient locally advance metastatic breast cancer Indication Halaven treatment : patient pretreated anthracyclines taxanes , patient receive least 1 chemotherapy regimen advance metastatic stage Patient enough time retrieve hair whose last chemotherapy regimen n't induce alopecia . Aged ≥ 18 year Nonopposition patient must collect Skin metastasis scalp Sensitivity cold , cold agglutinin disease cryoglobulinemia Impossibility submit study procedure due geographic , social mental reason</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>locally advanced breast cancer</keyword>
	<keyword>alopecia</keyword>
	<keyword>eribulin</keyword>
</DOC>